Closing the folate gap in reproductive-age women

Contemporary Ob/Gyn

Volumn 55, Issue 12, 2010, Pages

  Simpson, Joe Leigh ^a   Shulman, Lee P ^b   Brown, Haywood ^c   Holzgreve, Wolfgang ^d  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DUKE UNIVERSITY   (United States)

^d Institute for Advanced Study Berlin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651308971     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. use of supplements containing folic acid among women of childbearing age-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(1):5-8.
2. Kauwell GPA, Diaz M, Yang Q, Bailey LB. Folate: recommended intakes, consumption, and status. In: Bailey LB, ed. Folate in Health and Disease. 2nd ed. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2010:467-490.
3. Simpson JL, Bailey LB, Pietrzik K, Shane B, Holzgreve W. Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I-Folate, Vitamin B12, Vitamin B6. J Matern fetal Neonatal Med. 2010. doi:10.3109/14767051003678234.
4. Yang TL, Hung J, Caudill MA, Urrutia TF, Alamilla A, Perry CA, Li R, Hata H, Cogger EA. A long-term controlled feeding study in young women supports the validity of the 1.7 multiplier in the dietary folate equivalency equation. J Nutr. 2005;135(5):1139-1145.
5. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press; 1998.
6. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274(21):1698-1702.
7. Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet. 1980;1(8164):339-340. (Pubitemid 10219521)
8. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet. 1991;338(8760):131-137.
9. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327(26):1832-1835.
10. Berry RJ, Li Z, Erickson JD, et al. Prevention of neuraltube defects with folic acid in China. China-U. S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341(20):1485-1490.
11. Erratum in: N Engl J Med. 1999;341(24):1864.
12. Mills JL, Rhoads GG, Simpson JL, et al. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. National Institute of Child Health and Human Developmental and Neural Tube Defects Study Group. N Engl J Med. 1989;321(7):430-435.
13. Chanarin I. The Megaloblastic Anaemias. London, UK: Blackwell; 1969:786-829.
14. McPartlin J, Halligan A, Scott JM, Darling M, Weir DG. Accelerated folate breakdown in pregnancy. Lancet. 1993;341(8838):48-149.
15. Caudill MA, Gregory JF, Hutson AD, Bailey LB. Folate catabolism in pregnant and nonpregnant women with controlled folate intakes. J Nutr. 1998;128(2):204-208.
16. Higgins JR, Quinlivan EP, McPartlin J, Scott JM, Weir DG, Darling MR. The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG. 2000;107(9):1149-1154.
17. Gregory JF 3rd, Caudill MA, Opalko FJ, Bailey LB. Kinetics of folate turnover in pregnant women (second trimester) and nonpregnant controls during folic acid supplementation: stable-isotopic labeling of plasma folate, urinary folate and folate catabolites shows subtle effects of pregnancy on turnover of folate pools. J Nutr. 2001;131(7):1928-1937.
18. Landon MJ, Hytten FE. The excretion of folate in pregnancy. J Obstet Gynaecol Br Commonw. 1971;78(9):769-775.
19. Fleming AF. Urinary excretion of folate in pregnancy. J Obstet Gynaecol Br Commonw. 1972;79(10):916-920.
20. Bruinse HW, van den Berg H. Changes of some vitamin levels during and after normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 1995;61(1):31-37.
21. US Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. 21 CFR Parts 136, 137, and 139. Fed Regist. 1996;61(44):8781-8797.
22. Yang QH, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr. 2007;85(5):1409-1416.
23. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41(RR-14): 1-7.
24. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect. 1998;30(1):24-29, 46.
25. Cheschier N; ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001). Int J Gynecol Obstet. 2003;83(1):123-133.
26. US Preventive Services Task Force. Folic acid for the prevention of neural tube defects: US preventive services task force recommendation statement. Ann Intern Med. 2009;150(9):626-631.
27. Centers for Disease Control and Prevention. Trends in wheat-flour fortification with folic acid and iron-worldwide, 2004 and 2007. MMWR Morb Mortal Wkly Rep. 2008;57(1):8-10.
28. Botto LD, Mulinare J, Erickson JD. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet. 2003;121 A (2):95-101.
29. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet. 1996;62(2):179-183.
30. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet. 1995;59(4):536-545.
31. Scanlon KS, Ferencz C, Loffredo CA, et al. Preconceptional folate intake and malformations of the cardiac outflor tract. Baltimore-Washington Infant Study Group. Epidemiology. 1998;9(1):95-98.
32. Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA. Multivitamin supplementation and risk of birth defects. Am J Epidemiol. 1999;150(7):675-682.
33. Badovinac RL, Werler MM, Williams PL, Kelsey KT, Hayes C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol. 2007;79(1):8-5.
34. Mason JB, Dickstein A, Jacques PF, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1325-1329.
35. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer. 2005;113(5):825-828.
36. Mathers JC. Folate intake and bowel cancer risk. Genes Nutr. 2009;4(3):173-178.
37. Hubner RA, Houlston RS. Folate and colorectal cancer prevention. Br J Cancer. 2009;100(2):233-239.
38. Kim YI. Does a high folate intake increase the risk of breast cancer? Nutr Rev. 2006;64 (10 pt 1):468-475.
39. Figueiredo JC, Grau MV, Haile RW, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst. 2009;101(6):432-435.
40. Bramswig S, Prinz-Langenohl, Lamers Y, et al. Supplementation with a multivitamin containing 800 microg of folic acid shortens the time to reach the preventive red blood cell folate concentration in healthy women. Int J Vitam Nutr Res. 2009;79(2):61-70.